Checkpointinhibitoren in der Tumortherapie

In recent years, a breakthrough in tumor therapy was achieved with the development of checkpoint inhibitors. Checkpoint inhibitors activate the immune defense against tumors by overcoming the inhibitory effect of specific cell surface proteins acting as control points, the so-called checkpoints. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zander, Hilke, Müller-Egert, Susanne, Zwiewka, Michal, Groß, Steffen, van Zandbergen, Ger, Engelbergs, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648013/
https://www.ncbi.nlm.nih.gov/pubmed/33001218
http://dx.doi.org/10.1007/s00103-020-03221-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648013/
https://www.ncbi.nlm.nih.gov/pubmed/33001218
http://dx.doi.org/10.1007/s00103-020-03221-9

Ejemplares similares